ClinicalTrials.gov record
Completed Phase 2 Interventional

Lycopene in Treating Patients With Metastatic Prostate Cancer

ClinicalTrials.gov ID: NCT00068731

Public ClinicalTrials.gov record NCT00068731. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 2:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Trial Of Lycopene For Patients With Asymptomatic Androgen-Independent Metastatic Prostate Cancer With PSA Elevation

Study identification

NCT ID
NCT00068731
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Alliance for Clinical Trials in Oncology
Other
Enrollment
47 participants

Conditions and interventions

Interventions

  • lycopene Dietary Supplement

Dietary Supplement

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2003
Primary completion
Jan 31, 2007
Completion
Sep 30, 2009
Last update posted
Jul 12, 2016

2004 – 2009

United States locations

U.S. sites
18
U.S. states
12
U.S. cities
18
Facility City State ZIP Site status
CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale Arizona 85259-5404
Mayo Clinic - Jacksonville Jacksonville Florida 32224
CCOP - Atlanta Regional Atlanta Georgia 30342-1701
CCOP - Illinois Oncology Research Association Peoria Illinois 61615-7828
CCOP - Carle Cancer Center Urbana Illinois 61801
CCOP - Cedar Rapids Oncology Project Cedar Rapids Iowa 52403-1206
CCOP - Iowa Oncology Research Association Des Moines Iowa 50309-1016
Siouxland Hematology-Oncology Sioux City Iowa 51101-1733
CCOP - Wichita Wichita Kansas 67214-3882
CCOP - Ochsner New Orleans Louisiana 70121
CCOP - Duluth Duluth Minnesota 55805
Mayo Clinic Cancer Center Rochester Minnesota 55905
Coborn Cancer Center Saint Cloud Minnesota 56303
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416
Medcenter One Health System Bismarck North Dakota 58501-5505
CCOP - Dayton Dayton Ohio 45429
CCOP - Upstate Carolina Spartanburg South Carolina 29303
CCOP - Sioux Community Cancer Consortium Sioux Falls South Dakota 57104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00068731, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 12, 2016 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00068731 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →